# Study of Biochemical Markers to Determine the Acetylsalicylic Acid Chemopreventive Effect Through Antiplatelet Action

> **NCT02060396** · PHASE1 · COMPLETED · sponsor: **Aragon Institute of Health Sciences** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Acetylsalicylic acid

## Key facts

- **NCT ID:** NCT02060396
- **Lead sponsor:** Aragon Institute of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02060396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02060396, "Study of Biochemical Markers to Determine the Acetylsalicylic Acid Chemopreventive Effect Through Antiplatelet Action". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02060396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*